INTERVIEW: Russian medtech industry keeps close watch on pace of regulatory reform
This article was originally published in Clinica
A lot has happened to reshape Russia’s medical devices regulatory system within a very short time. Credit is due to the health ministry and Roszdravnadzor, the healthcare regulatory and surveillance agency, for embarking on the changes – however rocky the path has been at times. But it’s not the finished article, and industry will keep up the pressure in bid to secure a workable and forward-looking system, as IMEDA executive director Alexandra Tretiakova tells Ashley Yeo
You may also be interested in...
Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.
The consensus among investors is that medtech has been the best-performing part of health care for the past three to four years, and investment levels remain good. Seemingly all-encompassing of late has been companies’ preoccupation with digital strategies, but there is a lot more to this unique industry than just digital.
With fewer than a hundred days left before the EU Medical Device Regulations kick in, Medtech Insight’s executive editor Ashley Yeo and managing editor Amanda Maxwell discuss in this week's podcast growing concerns by medtech industry members that they may not be ready in time to comply with the regulations and may inadvertently run afoul of them.